This company seems to have been delisted
Reason: Acquired by Kyowa Kirin
Last recorded trade on: March 20, 2024
Source: https://www.ns-healthcare.com/news/kyowa-kirin-wraps-up-acquisition-of-orchard-therapeutics/
Reason: Acquired by Kyowa Kirin
Last recorded trade on: March 20, 2024
Source: https://www.ns-healthcare.com/news/kyowa-kirin-wraps-up-acquisition-of-orchard-therapeutics/
Orchard Therapeutics
ORTX
A$25.63
Share price
0.00%
Change (1 day)
245.66%
Change (1 year)
EPS for Orchard Therapeutics (ORTX)
EPS in 2023 (TTM): A-$10.93
According to Orchard Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$10.90. In 2020 the company made an earnings per share (EPS) of A-$23.51 an increase over its 2019 EPS that were of A-$26.86.
EPS history for Orchard Therapeutics from 2019 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | A-$10.93 | |
| 2020 | A-$23.51 | -12.45% |
| 2019 | A-$26.86 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | A-$2.32 | -78.73% | Jersey |
 Novavax NVAX | A$4.67 | -142.82% | 🇺🇸 USA |
 Organovo ONVO | A-$17.68 | 62.25% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | A-$10.90 | 0.00% | 🇬🇧 UK |